Navigation Links
Description:The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
Company:AESCULAPDescription:The RTX3370 Telehealth Monitor is an interactive and simple to use device, designed specifically to improve the way of providing healthcare to patients outside hospitals suffering from chronic diseases such as heart failure, COPD and diabetes....
Company:RTX Telecom
Company:NIVEA
Company:Medtronic Neurological and SpinalDescription:The Atlas II HF systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. In patients indicated for an ICD, the Atlas II HF systems are also intended: to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients wh...
Company:St. Jude Medical, Inc.
Company:Machaon DiagnosticsDescription:PRIMEADVANCED is a nonrechargeable neurostimulator designed for people who do not have high energy needs or do not want the maintenance of a rechargeable battery, for the management of their pain. What makes RESTOREADVANCED and PRIMEADVANCED different from earlier generations of neurostimulators is the ease and efficiency with which they can be programmed to help relieve chronic pain. For clin...
Company:Medtronic Neurological and Spinal
Company:RNA MedicalDescription:AlloDerm is an acellular dermal matrix derived from donated human skin tissue supplied by US AATB-compliant tissue banks utilizing the standards of the American Association of Tissue Banks (AATB) and Food and Drug Administration's (FDA) guidelines. Since AlloDerm is regarded as minimally processed and not significantly changed in structure from the natural material, the FDA has classified it as b...
Company:LifeCell Corp.
Company:Cook Surgical
Company:AESCULAPDescription:The RTX3370 Telehealth Monitor is an interactive and simple to use device, designed specifically to improve the way of providing healthcare to patients outside hospitals suffering from chronic diseases such as heart failure, COPD and diabetes....
Company:RTX Telecom
Body Good-bye Cellulite Gel-Cream
Description:NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....Company:NIVEA
RESTOREADVANCED Neurostimulator
Description:RESTOREADVANCED is a rechargeable neurostimulator equipped with a battery that can be recharged. This battery has a 9-year FDA approved battery life. It is the longest lasting battery on the market. This is helpful to people who require stronger stimulation to relieve their pain. What makes RESTOREADVANCED and PRIMEADVANCED different from earlier generations of neurostimulators is the ease and...Company:Medtronic Neurological and SpinalDescription:The Atlas II HF systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. In patients indicated for an ICD, the Atlas II HF systems are also intended: to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients wh...
Company:St. Jude Medical, Inc.
Specialized Coagulation Testing
Description:Machaon Diagnostics is a clinical reference laboratory, specializing in the diagnosis, treatment and monitoring of hemostatic and thrombotic conditions. Started as a collaboration of four laboratory scientists, Machaon Diagnostics has a defined vision to deliver customizable reference lab testing to the healthcare and bioscience industries....Company:Machaon DiagnosticsDescription:PRIMEADVANCED is a nonrechargeable neurostimulator designed for people who do not have high energy needs or do not want the maintenance of a rechargeable battery, for the management of their pain. What makes RESTOREADVANCED and PRIMEADVANCED different from earlier generations of neurostimulators is the ease and efficiency with which they can be programmed to help relieve chronic pain. For clin...
Company:Medtronic Neurological and Spinal
Safe-Wrap Blood Collection Tubes
Description:Safe-Wrap tubes are heparinized glass capillary devices wrapped in a puncture-resistant film. These tubes are used for the collection of capillary blood samples for the measurement of pH, blood gases and electrolytes (excluding lithium) and can hold up to 220 L of sample....Company:RNA MedicalDescription:AlloDerm is an acellular dermal matrix derived from donated human skin tissue supplied by US AATB-compliant tissue banks utilizing the standards of the American Association of Tissue Banks (AATB) and Food and Drug Administration's (FDA) guidelines. Since AlloDerm is regarded as minimally processed and not significantly changed in structure from the natural material, the FDA has classified it as b...
Company:LifeCell Corp.
Surgisis EXL Hernia Repair Graft
Description:Used for implantation to reinforce soft tissue where weakness exists. Indications for use include repair of a hernia or body wall defect. Supplied sterile in peel-open packages. Intended for one-time use....Company:Cook Surgical
(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... AZ (PRWEB) June 19, 2013 Guests at ... healthy, wealthy and wise even if they don’t go to ... does require some early thought. , Crafty ... when they take advantage of the pet-friendly Scottsdale Paradise Valley ... Package . With at least 14 days advance notice, guests ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... Amerinet, Inc, a leading national ... to help Pacific Medical Centers implement a comprehensive ... than 17 percent over the organization’s previous clinical ... economies of scale and process standardization are two ... multi-site providers,” said Shawn Padilla, director of supply ...
(Date:6/19/2013)... lateral sclerosis (ALS), also known as Lou Gehrig,s Disease, ... classified into four distinct stages, report pathologists with the ... in the Annals of Neurology . This post-mortem ... for the first time, how the fatal degenerative disease ... nervous system to other regions of brain and spinal ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2[0] Brightree Debuts on List of Top 100 Healthcare Technology Companies[0] Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley[0] Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference[0] Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program[0] Staging system in ALS shows potential tracks of disease progression, Penn study finds
... is a Wholly Owned Subsidiary of Shamir, KIBBUTZ ... SHMR ) ("Shamir"), a leading provider of innovative,products ... it has,signed an agreement yesterday, June 30, 2008, pursuant ... ("Altra") from its minority,shareholder. Prior to this transaction, Shamir ...
... Conn., July 1 UTC Power, a United,Technologies Corp. ... supply St.,Helena Hospital in California,s Napa Valley with its ... will be in full,production in the summer of 2009., ... hospital and,part of Adventist Health, a not-for-profit health care ...
... July 1 Opus Healthcare Solutions, Inc.,a ... has named Ray,Bechtold, CPA, as controller. Based ... responsible for overseeing all accounting and financial,administrative ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joined ...
... RGEN ) announced today that Dr. Alfred L. ... Dr. Goldberg is currently a Professor of,Cell Biology at ... in,particular for elucidating the structure and function of the ... destroyed in,cells. In addition, he has made major contributions ...
... pain. This was the result of the analysis ... her colleagues and published in the current edition ... Int, 2008; 105[24]: 441-8). , http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60552 ... more than 8000 private persons in the course ...
... staying asleep increase as women go through menopause ... Waking up earlier than planned also increases through ... The study is published in the July 1 ... "Sleep difficulties, especially problems staying asleep, are relatively ...
Cached Medicine News:Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 2Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 3Health News:St. Helena's Hospital Orders New Model 400kW Fuel Cell From UTC Power 2Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 3Health News:Sleep problems associated with menopause vary among ethnic groups 2Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbHSt. Helena's Hospital Orders New Model 400kW Fuel Cell From UTC PowerOpus Healthcare Solutions Names Ray Bechtold as ControllerRepligen Elects Alfred L. Goldberg, Ph.D. to the Board of DirectorsSmokers suffer more back painSleep problems associated with menopause vary among ethnic groups
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... designed for rigid skeletal fixation, ... freedom in positioning the fixation ... fixation is designed for the ... positions. Craniotomies can be performed ...
Medicine Products:(Date:6/19/2013)... June 19, 2013 Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4). Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)... Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6[0] Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer[0] Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence[0] NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease
... ELGX ), developer of minimally invasive treatments ... three and nine months ended September 30, 2010. ... said, "Our strong results were driven by the effectiveness ... of the new Powerlink sizes and PowerFit aortic extensions ...
... PRINCETON, N.J., Oct. 27 Laureate Pharma, ... organization, announced today that they have entered ... produce AV-203, AVEO Pharmaceutical,s (Cambridge, MA) novel ... will include process development, protein production, purification ...
Cached Medicine Technology:Endologix Reports 30% Third Quarter 2010 Revenue Growth 2Endologix Reports 30% Third Quarter 2010 Revenue Growth 3Endologix Reports 30% Third Quarter 2010 Revenue Growth 4Endologix Reports 30% Third Quarter 2010 Revenue Growth 5Endologix Reports 30% Third Quarter 2010 Revenue Growth 6Endologix Reports 30% Third Quarter 2010 Revenue Growth 7Endologix Reports 30% Third Quarter 2010 Revenue Growth 8Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |